BMY SG&A Expense Growth
Bristol Myers Squibb · SG&A Expense Growth
BMY SG&A Expense Growth
Latest reported-13.63%period ending
BMY FY SG&A Growth (YoY) (0.00% → -13.63%)
Latest values, visible window
High-resolution chart · PNG
BMY sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -13.632% | |
| 8.2604% | |
| -0.5375% | |
| 1.6125% | |
| 0.3785% | |
| 57.2778% | |
| 7.0314% | |
| -4.2096% | |
| -4.5792% | |
| -0.4399% | |
| -12.2478% | |
| 11.6575% | |
| -1.372% | |
| 0.0967% | |
| 10.211% | |
| -10.0307% | |
| -2.6149% | |
| -15.2848% | |
| 2.9316% | |
| -4.8505% | |
| 0.4045% | |
| 6.4954% | |
| 14.5814% | |
| 1.425% | |
| -6.128% | |
| 3.6343% | |
| 2.5947% | |
| -18.8806% | |
| 9.2489% | |
| 10.4402% | |
| 17.2733% | |
| -24.21% | |
| -5.6476% | |
| 16.0351% | |
| 8.4574% | |
| -7.578% | |
| 26.6264% | |
| 13.592% | |
| 0% |